z-logo
open-access-imgOpen Access
Geography Should Not Be an “Oncologic Destiny” for Urothelial Cancer: Improving Access to Care by Removing Local, Regional, and International Barriers
Author(s) -
Monika Joshi,
Hyma Polimera,
Tracey L. Krupski,
Andrea Necchi
Publication year - 2022
Publication title -
american society of clinical oncology educational book
Language(s) - English
Resource type - Journals
eISSN - 1548-8756
pISSN - 1548-8748
DOI - 10.1200/edbk_350478
Subject(s) - radiation oncologist , multidisciplinary approach , urothelial cancer , medicine , cancer , health care , family medicine , radiation therapy , bladder cancer , economic growth , political science , law , economics
Urothelial cancer care is particularly susceptible to geographical health disparity given its complex nature, requiring access to several specialists such as a urologist, a medical oncologist, a radiation oncologist, a surgical oncologist, and multidisciplinary care teams. Furthermore, other barriers to care access in underserved areas include travel burden, longer wait times, late-stage disease at the time of diagnosis, cost, type of treatment, less enrollment in clinical trials, lack of follow-up among cancer survivors, and less research funding in this area. Here, we discuss the impact of geographical location on access to urothelial cancer care, management decisions, and outcomes and we reflect on how to address geographical disparities in care delivery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom